PGE2-mediated inhibition of T cell p59(fyn) is independent of cAMP

American Journal of Physiology - Cell Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Choudhry, Mashkoor A ^a   Ahmed, Zulfiqar ^a   Sayeed, Mohammed M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Adenylate cyclase; Phosphodiesterase; Prostaglandin E2; Protein tyrosine kinase; Rat; Src kinase

Indexed keywords

8 BROMO CYCLIC AMP; 9 (TETRAHYDRO 2 FURYL)ADENINE; BUCLADESINE; FORSKOLIN; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE;

EID: 0032855696     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1999.277.2.c302     Document Type: Article

References (14)

1. Altman, A., T. Mustelin, and K. M. Goggeshall. T lymphocyte activation: a biological model of signal transduction. Crit. Rev. Immunol. 10: 347-391, 1990.
2. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148: 2845-2852, 1992.
3. Anderson, D. L., and C. D. Tsoukas. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J. Immunol. 143: 3647-3652, 1989.
4. Ayala, A., W. Ertel, and I. H. Chaudry. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5: 79-90, 1996.
5. Bartik, M., G. P. Bauman, W. H. Brooks, and T. L. Roszman. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell. Immunol. 158: 116-30, 1994.
6. 2 or beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell. Immunol. 158: 182-194, 1994.
7. Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
8. Berridge, M. J. Lymphocyte activation in health and disease. Crit. Rev. Immunol. 17: 155-178, 1997.
9. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108-113, 1991.
10. Bihoreau, C., A, Heurtier, A. Enjalbert, N. Corvaia, A. Bensussan, L. Degos, and C. Kordon. Activation of CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways. Eur. J. Immunol. 21: 2877-2882, 1991.
11. Bismuth, G., I. Theodorou, H. Gouy, S. Le Gouvello, A. Bernard, and P. Debre. Cyclic AMP-mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle-related transduction pathway. Eur. J. Immunol. 18: 1351-1357, 1988.
12. Cantrell, D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14: 259-274, 1996.
13. Chan, A. C., D. M. Desai, and A. Weiss. The role of protein tyrosine kinases and protein phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12: 555-592, 1994.
14. Walsh, D. A., and S. M. Van Patten. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J. 8: 1227-1236, 1994.